Sub Cat. No. |
Molecular Weight |
Glycan Name |
Inquiry |
X25-05-YM2137-1 |
PEG 350 Da |
WSW |
Inquiry
|
X25-05-YM2137-2 |
PEG 550 Da |
WSW |
Inquiry
|
X25-05-YM2137-3 |
PEG 750 Da |
WSW |
Inquiry
|
X25-05-YM2137-4 |
PEG 1 kDa |
WSW |
Inquiry
|
X25-05-YM2137-5 |
PEG 2 kDa |
WSW |
Inquiry
|
X25-05-YM2137-6 |
PEG 3 kDa |
WSW |
Inquiry
|
X25-05-YM2137-7 |
PEG 4 kDa |
WSW |
Inquiry
|
X25-05-YM2137-8 |
PEG 5 kDa |
WSW |
Inquiry
|
X25-05-YM2137-9 |
PEG 10 kDa |
WSW |
Inquiry
|
X25-05-YM2137-10 |
PEG 20 kDa |
WSW |
Inquiry
|
Properties
Description
WSW-PEG-glucose develops as a tripeptide-modified conjugate through chemical attachment of the tryptophan-serine-tryptophan sequence to PEG-connected glucose units, merging aromatic peptide interactions with PEG's solubility features and glucose's agricultural origin.
Source
Chemical synthesis
Impurities
No visible impurities to the naked eye.
Solubility
This product is soluble in most organic solvents, such as DCM, DMF, DMSO, and THF, and exhibits excellent solubility in water.
Identity
Confirmed by NMR.
Applications
Glucose-PEG-WSW peptide can be used for its potential to optimize WSW peptide-functionalized carriers for nuclear pore complex targeting.